Wells Fargo
ZOM

Wells Fargo’s Zomedica Corp. ZOM Stock Holding History

Wells Fargo’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-255,001
Closed -$30.6K – 7383
2024
Q4 		$30.6K Buy
255,001
+150,000
+143% +$18.9K ﹤0.01% 5636
2024
Q3 		$14.4K Buy
105,001
+77,483
+282% +$10.9K ﹤0.01% 5717
2024
Q2 		$4.02K Sell
27,518
-9,427
-26% -$1.41K ﹤0.01% 5912
2024
Q1 		$5.39K Sell
36,945
-112
-0.3% -$16 ﹤0.01% 5879
2023
Q4 		$7.42K Buy
37,057
+5,389
+17% +$947 ﹤0.01% 5900
2023
Q3 		$5.29K Buy
31,668
+1,092
+4% +$212 ﹤0.01% 5947
2023
Q2 		$6.12K Buy
30,576
+2,800
+10% +$568 ﹤0.01% 6041
2023
Q1 		$5.88K Buy
27,776
+102
+0.4% +$25 ﹤0.01% 6010
2022
Q4 		$4.51K Buy
27,674
+159
+0.6% +$33 ﹤0.01% 5805
2022
Q3 		$5K Sell
27,515
-43
-0.2% -$11 ﹤0.01% 5949
2022
Q2 		$6K Sell
27,558
-4,973
-15% -$1.27K ﹤0.01% 5976
2022
Q1 		$11K Buy
32,531
+19
+0.1% +$6 ﹤0.01% 6251
2021
Q4 		$10K Buy
32,512
+1,005
+3% +$453 ﹤0.01% 6561
2021
Q3 		$17K Sell
31,507
-8,762
-22% -$5.17K ﹤0.01% 6035
2021
Q2 		$33K Buy
40,269
+126
+0.3% +$117 ﹤0.01% 5724
2021
Q1 		$64K Buy
40,143
+36,470
+993% +$59.6K ﹤0.01% 5700
2020
Q4 		$1K Buy
3,673
+215
+6% +$27 ﹤0.01% 6419
2020
Q3 		$0 Buy
+3,458
New +$477 ﹤0.01% 7271
2020
Q1 		– Sell
-26,750
Closed -$9K – 7170
2019
Q4 		$9K Sell
26,750
-2,450
-8% -$824 ﹤0.01% 5930
2019
Q3 		$11K Sell
29,200
-2,093
-7% -$649 ﹤0.01% 5925
2019
Q2 		$7K Sell
31,293
-45,238
-59% -$13.7K ﹤0.01% 5992
2019
Q1 		$26K Sell
76,531
-1,332
-2% -$1.18K ﹤0.01% 5472
2018
Q4 		$96K Buy
77,863
+66,568
+589% +$106K ﹤0.01% 5306
2018
Q3 		$21K Sell
11,295
-561
-5% -$1.2K ﹤0.01% 5820
2018
Q2 		$27K Buy
11,856
+4,831
+69% +$9.7K ﹤0.01% 5756
2018
Q1 		$15K Buy
7,025
+5,750
+451% +$11.8K ﹤0.01% 5874
2017
Q4 		$3K Buy
+1,275
New +$2.83K ﹤0.01% 6160

Other funds holding ZOM

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $290M AUM 17.7% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

Wells Fargo's ZOM Position: Q1 2025 in Review

Wells Fargo sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 255,001 shares — an estimated $30.6K sold.

Wells Fargo first reported a position in ZOM in Q4 2017 and held it in 27 quarters. The position peaked at $96K in Q4 2018. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • Wells Fargo reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • Wells Fargo sold 255,001 Zomedica Corp. shares in Q1 2025, an estimated $30.6K.
  • Wells Fargo first reported a position in Zomedica Corp. in Q4 2017 and held it in 27 quarters.
  • Wells Fargo's Zomedica Corp. position peaked at $96K in Q4 2018.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on Wells Fargo's 13F filing for Q1 2025, filed 13 May 2025.